My size, inc. (MYSZ)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities:
Net loss

-1,459

-1,254

-1,350

-1,366

-1,527

-576

-1,561

1,591

-5,423

-1,885

-807

-1,318

-1,394

-214

-724

-3,507

111

-566

-1,614

-893

-364

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

9

9

8

-23

36

7

9

7

8

8

7

8

7

6

6

6

5

3

2

2

1

Reduction in the carrying amount of the right to use asset

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of warrants and derivatives

-2

-

-

-

-95

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in operating lease liabilities

-

-

-

-

39

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest of operating lease liabilities

-

-

-

-

-6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of warrant, convertible loans and derivative

-

-

-

-

-

-

-

-1,914

-

-

-

-122

-

-

-

-

-

-

-

-

-

Amortization of warrant, convertible loans and Derivative

-

-

-

-

-

-

-

-

-

-

-101

-

-29

-

117

-

-

-

-

-

-

Interest payment of short-term loan

-

-

-

-

-

-

-

0

192

323

0

0

0

-

-

-

-

-

-

-

-

Interest and revaluation of short-term deposit

-

0

324

-323

54

-105

-1,968

-1,914

3,874

-

-

-

-

-

-

-

-

-

-

-

-

Interest received from short-term deposit

-

0

-38

38

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of warrant, convertible loans and derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,757

-614

-

-

-

-

Revaluation of PUT Option

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

Revaluation of investment in marketable securities

-12

49

42

-81

185

215

87

-237

-188

151

132

0

340

-

0

0

-

-

-

-

-

Valuation of warrants and derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,525

0

0

Accrued interest on loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

397

2

Valuation of warrant to purchase Common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

Stock based compensation

70

125

145

322

100

102

110

90

231

206

53

34

39

10

-39

56

-50

53

145

104

96

Stock based compensation - liability

-

-

-

-

-

-6

25

16

434

1,031

88

178

0

-

0

-

-

-

-

-

-

Change in embedded derivative

-

-

-

-

-

-

-

61

-

-1

27

-159

6

-

0

0

0

-

-

-

-

Decrease in accounts receivables

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in other receivables and prepaid expenses

-95

-105

315

-84

-43

-134

17

-23

-2

99

-61

-62

8

-16

39

-11

15

63

-41

-4

-35

Decrease in trade payable

-164

-48

254

-81

-8

58

-34

69

-22

-73

127

-9

-54

53

-62

40

56

-

-

-

-

Increase in accounts payable

14

68

-83

61

30

21

-1

-141

84

-108

-60

75

93

-

-

-

-

-

-36

18

-29

Increase in deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Increase (decrease) in other accounts payable

-

-

-

-

-

-

-

-

-

-

-60

-

-

-

57

52

28

-4

20

12

18

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-527

-

-1,012

-

-684

-585

-479

-526

-316

-378

-219

Net cash used in operating activities

-1,436

-1,336

-1,658

-1,225

-1,199

-799

-1,049

-557

-1,192

-

-

-933

-

-

-

-

-

-

-

-

-

Cash flows from investing activities:
Proceeds from restricted deposits

-

-

-

-1,019

-181

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term deposits

-

-

-

-

1,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment in right-to-use asset

-25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

2

82

6

9

6

16

15

8

1

8

1

4

3

5

8

10

13

26

7

5

9

Repayment of a loan

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

25

0

-

-

-

-

Proceeds from realization of guarantees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Proceeds from Issuing shares, warrants and convertible loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Proceeds from issuance of shares, warrants and convertible loans

-

-

-

-

-

-

-

-

-

-

491

-

-

-

739

304

-

-

-

-

-

Net cash provided by (used in) investing activities

-27

-287

-6

-9

1,375

983

-2,395

-8

-1

-

-

-4

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Proceeds from exercise of warrants and options

-

-

-

-

-

0

80

239

3,626

-

-

0

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares, net of issuance costs

1,694

-

-

-

-

-274

0

0

5,923

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-1

-

-3

-

-8

-10

-13

-26

-7

-5

-9

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Repayment of short-term loan

-

-

-

-

-

-

-

0

-

250

0

10

0

-

-

-

-

-

-

-

-

Repayment of short term loan, net of issuance costs

-

-

-

-

-

1

0

0

-555

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of shares, warrants, short term loan and convertible loan

-

-

-

-

-

-

-

0

-

-

-

666

1,349

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,694

-

-

-

-

-273

80

239

8,994

-

-

656

-

-

-

-

-

-

-

-

-

Effect of exchange rate fluctuations on cash and cash equivalents

-6

0

75

95

145

-164

57

-348

-209

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash, cash equivalents and restricted cash

225

-1,357

-1,589

-1,139

321

-253

-3,307

-674

7,592

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of Common stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

491

-

1,349

-

739

279

0

-174

1,412

525

0

Effect of exchange rate fluctuations on cash and cash equivalents

-

-

-

-

-

-

-

-348

-

29

-77

53

-5

-

-2

-11

-2

16

-5

-5

-9

Increase (decrease) in cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-674

-

-

-

-228

329

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-114

-

-

-109

45

-327

-494

-710

1,084

137

-237

Non cash activities:
Exercise of warrants and stock-based compensation to equity

-

-

-

-

-

0

110

300

4,293

60

0

0

0

-

-

-

-

-

-

-

-

Derivative liability settles for shares issued

-

-

-

-

-

-

-

104

-

-

-

0

-

-

-

-

-

-

-

-

-

Warrants reclassified to equity as a result of amended exercise price currency

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

1,041

-

-

-

-

Warrants reclassified to equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Conversion of loan to equity

-

-

-

-

-

-

-

-

-

-

0

-

-

4,846

0

0

0

-

-

-

-

Non cash share base payments

-

-

-

-

-

-

-

-

-

-

-

-

958

-

-

-

0

-

-

-

-

Warrants reclassified to equity as a result of amended exercise price currency

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0